Muñeca

Hoy cuando estábamos reunidos, en esta fecha celebrábamos la fecha de tu nacimiento, y recordábamos a Marcelino y Anita, tus padres, hoy con ellos tú me recuerdas a mí, reunida con ellos.

Tu ausencia, no ha sido fácil para mí, que dependía tanto de ti, pero al saberte tan bien acompañada, y que estas guardando lugar para mí, el dolor se convierte en alegría, y anhelo ese día en que celebremos juntos allá.

Nuestras horas en el amor tuvieron alas; en tu ausencia, se convirtieron en muletas, y poco a poco tu ausencia, comenzó lentamente, pero firmemente a destrozarme.

Hoy casi acabado quiero recordarte, pero más para aquellos que admiraron nuestra unión, que vives en mi corazón. Hasta el último día que Dios me tenga por acá.

Mi Ayuda Para Hoy

 

Los jóvenes y también las doncellas, los ancianos y los niños alaben el nombre de Jehová

Salmo 148:12-13

Cuando vivimos una vida de alabanza a Dios, muestra que nuestra fe está constantemente en el contacto directo con Dios. Hacemos de ese contacto una bendición y a la vez nuestra prioridad.

Cuando tienes alabanzas a Dios cuando empiezas tu día, la escritura dice que Dios Todopoderoso irá a la guerra contra tus enemigos. Deuteronomio: 20:4

Tú puedes hacer más que orar después de haber orado, pero no puedes hacer nada más que orar, hasta que no hayas orado. Empieza tu día con una oración, agradas a Dios y todo te saldrá de Bendición.

 

Mi Ayuda Para Hoy

¿Te estás perdiendo las alegrías de la vida porque estás demasiado ocupado? Dios te llamó para ser feliz, y disfrutar del mañana que te da en cada día; Nunca te llamó para estar ocupada que no puedas ni recibir las bendiciones que cada minuto tiene para ti, no Te pierdas el gozo de meditar en las bendiciones y futuras alegrías.

 Sólo porque usted está en el afán del día a día y siempre haciendo cosas, no significa necesariamente que usted está cumpliendo el mejor plan de Dios para su vida. Todo en trabajar y ningún goce, ni disfrute de tus bendiciones, no es saludable. Pídale al Señor que te muestre qué áreas necesitan ser cortadas y qué áreas necesitan más atención. Pídele que te muestre Qué relaciones dejar ir y qué relaciones desarrollar en tu vida.

Deje de permitir que las áreas improductivas de tu vida consuman todo tu tiempo, atención y energía. A medida que realice ajustes para llevar el equilibrio a tu día a día, tendrás más espacio para las actividades y las relaciones que te traerán alegría y paz, y que Dios te dio, porque tu te lo pediste, pero esta vez sí escúchalo y actúa en la bendición que Dios te dio con este nuevo día. Bendecido tu eres. Amen.

 

Chukar Cherries of Prosser, WA is recalling 7.5oz Amaretto Rainier Ultra Dark Chocolate Cherries because they may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product.

February 18, 2019, Chukar Cherries of Prosser, WA is recalling 7.5oz Amaretto Rainier Ultra Dark Chocolate Cherries because they may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product.

The 7.5oz Amaretto Rainier Ultra Dark Chocolate Cherries were distributed in CA, CO, MD, ME, OR, and WA through retail stores. The product is sold in plastic pouches, UPC 0 11261 22307 7, and a Best By date of 11/2019 is found underneath the UPC code on the back side of the package.

No allergic reaction has been reported to date.

The recall was initiated after it was discovered that Amaretto Rainier Ultra Dark Chocolate Cherries containing milk was distributed in packaging that did not reveal the presence of milk.

This recall is being made with the knowledge of the U.S. Food and Drug Administration.

The company revised labels on new lots to include the allergen advisory statement since November 2018.   Consumers who have questions or have purchased the recalled product may contact Chukar Cherries at 1-509-786-2055 from 8am to 5pm Consumers Chukar Cherries 509-786-2055

Source: U.S. Food & Drug Administration Feb.18,2019

   

Birdseed Food Co. Issues Allergy Alert on Undeclared Cashews in Craft Granola Goldenola Turmeric & Ginger

          

Birdseed Food CO. of Bend, OR is recalling Craft Granola Goldenola Turmeric & Ginger that was sold between the dates of 10/03/18 – 02/07/19, because it contains undeclared cashews. People who have an allergy or severe sensitivity to cashews run the risk of serious or life-threatening allergic reaction if they consume this product.

Craft Granola Goldenola Turmeric & Ginger was distributed in CA, CT, MD, NY, OR and PA at retail stores (https://www.birdseedfoodco.com/pages/where-to-find) as well as sold online through https://www.birdseedfoodco.com/collections/all, https://getintothebubble.com/, and https://www.farmtopeople.com/

The product can be identified as the yellow bag, net weight 11oz and 3oz, packaging with all expiration dates and includues up to 061419.

No illnesses have been reported to date in connection with this problem as of 02/07/19.

The mislabeling of the product happened upon attaining new packaging in October 2018 and the firm became aware of the issue via customer email. Moving forward the cashew ingredient will be removed from recipe.

Consumers who are allergic to cashews urged not to consume product. If a consumer would like their product replaced or if in need of any further information, please contact Ashley at 541-788-6352.

Source: U.S. Food & Drug Administration.- Feb 8 2019

Felt, OK, McDaniel Life-Line LLC is voluntarily recalling all lots of Indian Herb to the consumer level. This product is being recalled because it is marketed without an approved NDA/ANDA. The therapeutic claims made in the labeling for this product establish that it is a drug because it is an article (other than food) intended to affect the structure or any function of the body.  Additionally, the product contains ingredients that the Agency has determined to be caustic in nature that can cause serious injury.

Use of the product could result in temporary or permanent damage or loss of body function or structure.  To date, McDaniel Life-Line LLC has received a report of one adverse injury.

The product can be taken internally or applied externally to abnormal skin growths. The product is  packaged in 6 dram vials. The affected Indian Herb includes all lots.  Product was distributed in the United States, Italy, Canada, Australia and Poland to individuals via internet sales@lifelinewater.com.

McDaniel Life-Line LLC is notifying its customers by press release of the recalled product. Consumers that have product which is being recalled should stop using and discard.

Consumers with questions regarding this recall can contact McDaniel Life-Line by phone 806-647-1471 or by e-mail lifeline@amaonline.com, Monday thru Friday 8 AM-5 PM, Central Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

McDaniel Life-Line
  lifeline@amaonline.com
 806-647-1471

Source: U.S. Food & Drug Administration 02/08/2019

 

Mi Ayuda Para Hoy

My Ayuda Diaria

Mi Ayuda Para Hoy

Mañana no te fallará nunca, porque siempre habrá un mañana, a menos que tú no estés en este mundo, si es así, para ti ya no habrá un mañana.

Es en tus momentos de decisión que tu destino se forma, y es Tu esfuerzo completo el que es tu victoria completa

No cuesta nada comprar un sueño y menos si es de tú mente corazón y deseo, sueña y vive como un Bendecido que es lo que tú eres.

  

Frito-Lay announced a limited voluntary recall of a very small number of 7 1/3 oz. bags of Stacy’s Simply Naked Pita Chips because they may contain undeclared milk ingredients. People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume the product contained inside the recalled pita chips bags.

The recalled products are 7 1/3 oz. bags of Stacy’s Simply Naked Pita Chips that were distributed nationwide and have both a “Use By” date of 23 APR 2019 and a nine-character manufacturing code of “65M127902” listed below the “Use By” date. These numbers can be found on the front of the bag along the top right side. In addition, the recalled bags will also have a UPC code of “028400564632” listed on the bottom right side of the back of the bag.

No other Stacy’s products or flavors are recalled.

The recall was initiated after it was discovered that 228 bags of Stacy’s Simply Naked Pita Chips were inadvertently filled with another flavor of pita chips, potentially exposing consumers to undeclared milk.

One consumer allergic reaction related to this matter has been reported to date.

Frito-Lay has informed the FDA of our actions.

 

Consumers with the product noted above can return the product to a retailer for a refund or contact Frito-Lay Consumer Relations at 1-800-352-4477 (9 a.m. – 4:30 p.m. CST, Monday-Friday

Source: U.S. Food & Drug Administration

 

Stryker Launches Voluntary Field Action for Specific Units of the LIFEPAK® 15 Monitor/Defibrillator

The company is notifying certain LIFEPAK 15 customers of an issue that may cause the device to lock up after a defibrillation shock is delivered. The lock-up condition is defined as a blank monitor display with LED lights on, indicating power to the device, but no response in the keypad and device functions. A device in this condition has the potential to delay delivery of therapy, and this delay in therapy has the potential to result in serious injury or death.

The company is contacting customers with impacted devices to schedule the correction of their device(s), which will include an update to the firmware for a component on the System Printed Circuit Board Assembly.  Stryker anticipates that all devices subject to this field action will be serviced by December 31, 2019.  If a customer experiences this issue, they should contact Stryker as soon as possible at 1 800 442 1142 and selecting option 7.

Since the initial commercialization of LIFEPAK 15 in 2009, Stryker has become aware of 58 complaints reported globally for this issue, including 6 events in which the patient died following a delay in therapy. In all six of these cases, at least one shock was delivered prior to the device experiencing the lock-up condition. There are 13,003 devices potentially impacted by this issue and within scope of this field action.

The company is instructing customers to continue to use their LIFEPAK 15 Monitor/Defibrillator according to the Operating Instructions until the correction can be completed.  Device Automatic Self-Tests do not identify this fault, as it occurs during defibrillation.  Customers should continue to perform the daily check as described in the Operator’s Checklist, specifically, the QUIK-COMBO therapy cable check as described in the General Maintenance and Testing Section (pages 10-4 and the LIFEPAK 15 Monitor/Defibrillator Operator’s Checklist, number 7).

If a device exhibits the lockup condition during patient use, the steps from the General Troubleshooting Section (page 10-18) of the LIFEPAK 15 Monitor/Defibrillator Operating Instructions should be immediately followed:

Press and hold ON until the Stryker announced today that the company is launching a voluntary field action on specific units of the LIFEPAK 15 Monitor/Defibrillators.

1. LED turns off (~5 seconds). Then press ON to turn the device back on.
2. If the device does not turn off, remove both batteries and disconnect the device from the power adapter, if applicable. Then reinsert batteries and/or, reconnect the power adapter, and press ON to turn the device back on.

Information about this notice is available at: http://www.strykeremergencycare.com/productnotices. Impacted customers will be notified by letter and will be requested to verify their device status. Customers with questions regarding this notification, please contact Stryker by calling 1 800 442 1142, option 7, 6:00 a.m. to 4:00 p.m. (Pacific) Monday – Friday, or by email to rsfa281@stryker.com or fax to 1 425 867 4948.

Source: U.S. Food & Drug Administration

Tris Pharma, Inc Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen

Monmouth Junction, NJ, Tris Pharma, Inc. is expanding the scope of its November 2018 recall by adding three (3) additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, to the retail (pharmacy) level. Some units from these batches have been found to have higher levels of Ibuprofen concentration.

Infants already susceptible to the adverse effects of ibuprofen may be at a slightly higher risk if they receive medication from an impacted bottle. There is a remote probability that infants, who may be more susceptible to a higher potency level of drug, may be more vulnerable to permanent NSAID-associated renal injury. Some units from these six (6) lots have been found to contain Ibuprofen as high as 10% above the specified limit. Studies have shown that safety issues or toxicity is generally accepted to be a concern in infants at doses in excess of 700% of the recommended dose.1 To date, no serious adverse events have been reported related to this recall.

Consumers with questions regarding this recall may contact Tris Customer Service by 732-940-0358 (Monday through Friday, 8:00 AM ET- 5:00 PM PT) or via email at micc_tris@vigilarebp.com. Consumers, who may be concerned, should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Source: U.S. Food & Drug Administration Jan.30,2019